SHENZHEN PRO HITU MEDICAL CO., LTD.

  • Company News

2019-11-01

PRO successfully held the 2019 Global HIFU User Communication Conference

Share:
1632
a93fd0db2f7937ae16a315fa10019e21-sz_255648.webp.jpg

Zhang Ji, President of PRO, and Peng Lingling, Manager of Clinical Department, attended the opening ceremony and delivered speeches. They extended a warm welcome to the experts and peers who came from afar and thanked them for their support for PRO. In addition, they hoped that this event would allow more patients to experience high-intensity focused ultrasound therapy (HIFU).

e49849a17eece49bfa324e14106386b3-sz_267279.webp.jpg

Academic Lectures

Prof. Luo Xiping: Sharing of experience in the diagnosis and treatment of special uterine fibroid cases

At the beginning of the conference, Prof. Luo Xiping from Guangdong Provincial Maternal and Child Health Hospital shared his experience in the diagnosis and treatment of special uterine fibroid cases. HIFU technology has greatly diversified gynecological treatments, bringing good news to more female patients.

d15e5218d2083494fcf8efca9d023662-sz_208302.webp.jpg


Prof. Zheng Wei: The strategy for the treatment of adenomyosis patients with fertility requirements

Prof. Zheng Wei from the Second Affiliated Hospital of the Zhejiang University School of Medicine shared "the strategy for the treatment of adenomyosis patients with fertility requirements" based on relevant cases. By sharing the causes of adenomyosis and current clinical treatments, Prof. Zheng introduced the concept of comprehensive treatment of adenomyosis.

fdee57e41565d06ea2c8066087654fe7-sz_263578.webp.jpg


Prof. Geng Jing: Sharing of the effect of HIFU therapy for uterine fibroids and adenomyosis

Prof. Geng Jing from Peking University People's Hospital shared with the audience a case study of her hospital's HIFU therapy based on the effect of the treatment of uterine fibroids and adenomyosis. In addition, Prof. Geng summarized some of the issues that may occur during treatment.

01b30998f5e3b0ea6251f77657cfae7e-sz_287774.webp.jpg


Director Wang Fang: HIFU therapy for malignant tumors

Director Wang Fang from the First Affiliated Hospital of Nanchang University talked about the mechanism of HIFU therapy for malignant tumors, the related cases and precautions. Director Wang then gave an outlook on HIFU therapy for malignant tumors based on relevant postoperative survival records and postoperative analysis for malignant tumors of different natures.

b4b0514b817b83794e70a4a8f20c3fa0-sz_237270.webp.jpg


Director Liu Yan: How should we avoid and manage common complications?

Director Liu Yan from Zhengzhou TCM Hospital shared with the audience in detail some common complications after HIFU therapy and postoperative care based on her experience.

0792ce752c98045b74295afc86ede7a4-sz_270849.webp.jpg


Prof. Chen Dexin: HIFU application in reproductive medicine

Prof. Chen Dexin from Sichuan Provincial Maternity and Child Health Care Hospital introduced the concept of HIFU application in reproductive medicine based on uterine fibroids and adenomyosis. He elaborated on the superiority of HIFU technology in the treatment of uterine fibroids.

43f61d8b7cc362babdeebddbde8e3db8-sz_262748.webp.jpg


Director Ta-Chin Lin: Sharing of Taiwan's HIFU experience

Director Ta-Chin Lin from Kuo General Hospital in Taiwan offered the audience new ideas about HIFU therapy. Director Lin shared the history of treating uterine fibroids in Taiwan. As an infertility specialist, Director Lin is confident and excited about the future of HIFU technology. Medical technology has evolved from surgical procedures to non-invasive treatments. More and more female patients in Taiwan have enjoyed the benefits of focused ultrasound.

dc95cf143423cad7a075ad55a28d341a-sz_267811.webp.jpg


Director Yu Hongjin: How should we promote the smooth implementation of HIFU programs in the hospital?

Based on her management experience, Director Yu Hongjin from Dongguan Maternal and Child Health Hospital provided the audience with new ideas on how to manage HIFU teams. She talked about how to make focused ultrasound treatment more popular through process-based management of the HIFU center and mutual promotion between departments.

52bc27533d7ecdf7ea25d1a04ffd20cb-sz_244399.webp.jpg


fe96e0dde71d28d437fe47b534eb603a-sz_267126.webp.jpg

Mr. Zhang Ji, President of Shenzhen Shengke Biomedical Research Institute, delivered a speech on "The Progress of Cavitation in Tumor Treatment". By telling his own story, Mr. Zhang introduced ultrasound development from diagnosis to treatment and analyzed the advantages, disadvantages and future of HIFU technology. Mr. Zhang envisioned the all-round development of focused ultrasound in the future and also expected to embrace the wonderful era of non-invasive treatment together with everyone in the near future.

4a4fbba6b48c16fc9dc009c3bf18c895-sz_213322.webp.jpg

At the end of the conference, Peng Lingling, Manager of the Clinical Medicine Department of PRO, gave a presentation on "Hot-Spot HIFU Therapy Issues". She also interacted with experts and scholars and answered questions for doctors.

ea79253a69ee30b307aa072c5acc3df0-sz_324209.webp.jpg

After the conference, PRO awarded appointment certificates to several experts and arranged a sumptuous dinner and band performance. The day-long conference ended perfectly with cheers and laughter.

a6b5d348926cc1e287da97d21d464fda-sz_228102.webp.jpg

This conference brought together more than 100 HIFU experts from around the world. PRO has strengthened academic exchanges with hospitals in different regions, encouraged focused ultrasound users to share their experience and promoted the development of non-invasive medical treatment through this conference.

PRO believes that the end of the conference means the beginning of the achievement of new goals. PRO can fully meet the needs of experts and users in terms of treatment safety and product efficacy. PRO will explore broader areas in the future. We will stay true to our founding mission and forge ahead.